Related Experiment Video
Updated: May 24, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Suppression of ERR targets by a PPARα/Sirt1 complex in the failing heart
Shin-ichi Oka1, Peiyong Zhai, Ralph Alcendor
1University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.
Abstract:
Heart failure is a leading cause of death worldwide. Estrogen-related receptors (ERRs) are a nuclear receptor subfamily that facilitates the transcription of contractile and nucleus-encoded mitochondrial genes in the heart. Impaired expression of these ERR target genes is frequently observed in human heart failure patients. However, the responsible molecular mechanism is not well-understood. Recently, we have shown that PPARα forms a protein complex with Sirt1, which is involved in the downregulation of ERR targets through direct interaction with the ERR response element (ERRE) in the failing heart. Here, we provide additional lines of evidence supporting the pathological involvement of the PPARα/Sirt1 complex in heart failure. Pressure overload-induced left ventricular (LV) hypertrophy was attenuated in mice with heterozygous knockout of either PPARα (PPARα (+/-) ) or Sirt1 (Sirt1 (+/-) ), whereas cardiac-specific PPARα and Sirt1 bigenic mice showed LV hypertrophy accompanied by a high mortality rate even without pressure overload. Microarray analyses indicated that nuclear-encoded mitochondrial genes were largely downregulated and mitochondrial morphological abnormalities were observed in PPARα/Sirt1 bigenic mice. Those downregulated mitochondrial genes frequently harbor the ERRE in the promoter regions. Artificial and physiological PPARα ligands suppressed reporter genes driven by the ERREs. PPARα bound to and recruited Sirt1 to the genomic flanking region of the ERREs in the heart. Pressure overload downregulated many ERR targets, which were partly normalized by PPARα (+/-) and Sirt1 (+/-) mice. These results suggest that PPARα and Sirt1 downregulate ERR target gene expression through direct interaction with the ERRE in the failing heart.
Insights
The PPARα/Sirt1 complex in the heart downregulates estrogen-related receptor (ERR) target genes, contributing to heart failure. This mechanism involves direct interaction with the ERR response element (ERRE) in failing hearts.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Nuclear Receptor Signaling
Background:
- Heart failure is a major global health issue.
- Estrogen-related receptors (ERRs) regulate cardiac genes essential for contraction and mitochondrial function.
- Dysregulation of ERR target genes is common in heart failure, but the underlying mechanisms are unclear.
Purpose of the Study:
- To investigate the pathological role of the PPARα/Sirt1 complex in heart failure.
- To elucidate the molecular mechanism by which PPARα/Sirt1 influences ERR target gene expression in the failing heart.
Main Methods:
- Utilized mouse models with heterozygous knockout of PPARα or Sirt1, and cardiac-specific bigenic mice.
- Performed pressure overload to induce left ventricular hypertrophy.
- Conducted microarray analysis to assess gene expression, particularly of nuclear-encoded mitochondrial genes.
- Employed reporter gene assays and chromatin immunoprecipitation to study PPARα/Sirt1 interaction with ERREs.
Main Results:
- Heterozygous knockout of PPARα or Sirt1 attenuated pressure overload-induced cardiac hypertrophy.
- Cardiac-specific PPARα/Sirt1 bigenic mice exhibited hypertrophy and high mortality.
- PPARα/Sirt1 bigenic mice showed downregulation of nuclear-encoded mitochondrial genes and mitochondrial abnormalities.
- PPARα directly bound to and recruited Sirt1 to ERREs, suppressing ERR target gene expression.
Conclusions:
- The PPARα/Sirt1 complex plays a pathological role in heart failure by downregulating ERR target genes.
- Direct interaction of PPARα/Sirt1 with ERREs is a key mechanism contributing to cardiac dysfunction in heart failure.
- Targeting the PPARα/Sirt1 pathway may offer therapeutic strategies for heart failure.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management
The Unfolded Protein Response
Cardiomyopathy II: Dilated Cardiomyopathy
